Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Raptiva Pregnancy Registry: An Observational Study of the Use and Safety of Raptiva (Efalizumab) During Pregnancy

NCT00097240 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT00097240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00097240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Raptiva Pregnancy Registry: An Observational Study of the Use and Safety of Raptiva (Efalizumab) During Pregnancy
Lead sponsor
Genentech, Inc.
Phase
Observational
Overall status
Completed
Start date
January 31, 2005
Completion date
September 30, 2009
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy, psoriasis